Infliximab in pediatric Crohn disease patients with enterovesicular fistulas

Journal of Pediatric Gastroenterology and Nutrition

Volumn 44, Issue 2, 2007, Pages 279-282

  Teitelbaum, Jonathan E ^a   Saeed, Shehzad ^b   Triantafyllopoulou, Maria ^c   Daum, Frederic ^d  

^a MONMOUTH MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BUDESONIDE; CIPROFLOXACIN; COTRIMOXAZOLE; INFLIXIMAB; LEVOFLOXACIN; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; NITROFURANTOIN; PREDNISONE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; CYSTOSCOPY; DUODENUM; ENTEROVESICULAR FISTULA; ESCHERICHIA COLI; FEMALE; HUMAN; ILEUM; INTESTINE FISTULA; INTESTINE SURGERY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; STOMA; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINE CULTURE;

ADOLESCENT; ANTIBODIES, MONOCLONAL; CHILD; CROHN DISEASE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL FISTULA; MALE; TREATMENT OUTCOME; URINARY BLADDER FISTULA;

EID: 33846635983     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mpg.0000237933.38223.da     Document Type: Article

References (25)

1. Ten Kate J. Tweegevallen van ileitis terminalis. Ned Tijdschr Geneskd 1936;80:5660-4.
2. Crohn BB, Ginzberg L, Oppenheimer GD. Regional ileitis, a pathological and clinical entity. JAMA 1932;99:1323-9.
3. Talamini MA, Broe PJ, Cameron JL. Urinary fistulas in Crohn's disease. Surg Gynecol Obstet 1982;154:553-6.
4. McNamara MJ, Fazio VW, Lavery IC, et al. Surgical treatment of enterovesicular fistulas in Crohn's disease. Dis Colon Rectum 1990;33:271-6.
5. Saint-Marc O, Frileux P, Vaillant JC, et al. Enterovesicular fistulas in Crohn disease: diagnosis and treatment. Ann Chir 1995;49: 390-5.
6. Schwartz DA, Foftus EV, Tremaine WJ, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002;122:875-80.
7. Solem C. Fistulas to the urinary system in Crohn's disease: clinical features and outcomes. Am J Gastroenterol 2000;95:2551A.
8. Levy C, Tremaine WJ. Management of internal fistulas in Crohn's disease. Inflamm Bowel Dis 2002;8:106-11.
9. Sands BE, Anderson FH, Bernstein CN, et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 2004;350 (9):876-85.
10. Game X, Malavaund B, Mouzin AM, et al. Infliximab treatment of Crohn disease ileovesical fistula. Scand J Gastroenterol 2003;10:1097-8.
11. Colombel JF, Loftus EV Jr, Tremaine WJ, et al. The safety profile of infliximab in patients with Crohn's disease: the Mayo Clinic experience in 500 patients. Gastroenterology 2004;126:19-31.
12. Bongartz T, Sutton AJ, Sweeting MJ, et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 2006;295: 2275-85.
13. Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infections and mortality in association with therapies for Crohn disease: TREAT Registry. Clin Gastroenterol Hepatol 2006;4:621-30.
14. Luna-Chadid M, Perez Calle JL, Mendoza JL, et al. Predictors of response to infliximab in patients with fistulizing Crohn's disease. Rev Esp Enferm Dig 2004;96:379-81.
15. Meihsler W, Reinisch W, Kazemi-Shirazi L, et al. Infliximab: lack of efficacy on perforating complications in Crohn's disease. Inflamm Bowel Dis 2004;10:36-40.
16. Gilberts E, Greenstein A, Katsel P, et al. Molecular evidence for two forms of Crohn's disease. Proc Natl Acad Sci U S A 1994;91: 12721-4.
17. Korelitz BI, Present DH. Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease. Dig Dis Sci 1985;30:58-64.
18. Margolin M, Korelitz B. Management of bladder fistula in Crohn's disease. J Clin Gastroenterol 1989;11:399-402.
19. Wheeler SC, Marion JF, Present DH. Medical therapy, not surgery, is the appropriate first line treatment for Crohn's enterovesical fistula. Gastroenterology 1998;114:A1113.
20. Glass RE, Ritchie JK, Lennard-Jones JE, et al. Internal fistulas in Crohn's disease. Dis Colon Rectum 1985;28:557-61.
21. Yamamoto T, Keighley MR. Enterovesical fistulas complicating Crohn's disease: clinicopathological features and management. Int J Colorectal Dis 2000;15:211-7.
22. Greenstein AJ, Sachar DB, Tzakis A, et al. Course of enterovesical fistulas in Crohn's disease. Am J Surg 1984;147:788-92.
23. Gorcey S, Katzka I. Is operation always necessary for enterovesicular fistula in Crohn's disease? J Clin Gastroenterol 1989;11: 396-8.
24. Biancone L, Orlando A, Kohn A, et al. Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicenter matched pair study. Gut 2006;55:228-33.
25. Kwon JH, Farrell RJ. The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents. Crit Rev Oncol Hematol 2005;56:169-78.